Trials / Conditions / Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
5 registered clinical trials studyying Long-chain Fatty Acid Oxidation Disorders (LC-FAOD).
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | A Study to Determine the Effect of Triheptanoin Compared With Even-Chain MCT on MCEs in Pediatric Patients Wit NCT05933200 | Ultragenyx Pharmaceutical Inc | Phase 3 |
| Terminated | Long-Chain Fatty Acid Oxidation Disorders Online Disease Monitoring Program NCT04812106 | Ultragenyx Pharmaceutical Inc | — |
| Active Not Recruiting | Long-Chain Fatty Acid Oxidation Disorders In-Clinic Disease Monitoring Program NCT04632953 | Ultragenyx Pharmaceutical Inc | — |
| Completed | Clinical Outcome of Triheptanoin Treatment in Patients With Long-chain Fatty Acid Oxidation Disorders (LC-FAOD NCT03768817 | Ultragenyx Pharmaceutical Inc | — |
| Completed | A Study of UX007 (Triheptanoin) in Participants With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) NCT01886378 | Ultragenyx Pharmaceutical Inc | Phase 2 |